Friday, December 5, 2008 - 3:49AM EST

Clinical Trials

11. Phase II study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer.

Author
Shirai T; Hirose T; Noda M; Ando K; Ishida H; Hosaka T; Ozawa T; Okuda K; Ohnishi T; Ohmori T; Horichi N; Adachi M;
Institution
The First Department of Internal Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Tokyo 142-8666, Japan. alicelov@t.toshima.ne.jp
Journal
Lung Cancer. 2006 May;52(2):181-7. Epub 2006 Mar 24.
Abstract URL
Click here to view abstract

12. A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.

Author
Pallis AG; Agelidou A; Papakotoulas P; Tsaroucha A; Agelidou M; Agelaki S; Androulakis N; Vamvakas L; Gerogianni A; Kotsakis A; Kentepozidis N; Georgoulias V;
Institution
Department of Medical Oncology, University Hospital of Heraklion, Greece.
Journal
Lung Cancer. 2006 May;52(2):165-71. Epub 2006 Mar 24.
Abstract URL
Click here to view abstract

13. Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.

Author
Cobo-Dols M; Gil-Calle S; Villar-Chamorro E; Ales-Diaz I; Carabantes-Ocon F; Alcalde-Garcia J; Gutierrez-Calderon V; Montesa-Pino A; Breton-Garcia JJ; Benavides-Orgaz M;
Institution
Medical Oncology Section, Hospital Regional Universitario Carlos Haya, Malaga, Spain. manuelcobodols@yahoo.es
Journal
Clin Transl Oncol. 2006 Jul;8(7):519-24.
Abstract URL
Click here to view abstract

14. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).

Author
Kudoh S; Takeda K; Nakagawa K; Takada M; Katakami N; Matsui K; Shinkai T; Sawa T; Goto I; Semba H; Seto T; Ando M; Satoh T; Yoshimura N; Negoro S; Fukuoka M;
Institution
Department of Respiratory Medicine, Osaka City University Medical School, Osaka, Japan. shinzohykudoh@med.osaka-cu.ac.jp
Journal
J Clin Oncol. 2006 Aug 1;24(22):3657-63.
Abstract URL
Click here to view abstract

15. Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.

Author
Gemma A; Seike M; Kosaihira S; Minegishi Y; Noro R; Nara M; Hosomi Y; Okano T; Kokubo Y; Yoshimura A; Shibuya M; Kudoh S;
Institution
Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo, Japan. agemma@nms.ac.jp
Journal
Anticancer Res. 2006 Jul-Aug;26(4B):3083-7.
Abstract URL
Click here to view abstract

16. Gemcitabine, ifosfamide, and cisplatin combination (GIP) in treatment of patients with locally advanced or metastatic nonsmall cell lung cancer: results of a phase II study.

Author
Planchard D; Bourgeois H; Adoun M; Paitel JF; Blanc P; Genet D; Ferru A; Meurice JC; Deletage C; Tourani JM;
Institution
Pneumology Unit, University Hospital of Poitiers, Poitiers, France. d.planchard@chu-poitiers.fr
Journal
Am J Clin Oncol. 2006 Aug;29(4):345-51.
Abstract URL
Click here to view abstract

17. Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.

Author
Inoue A; Suzuki T; Fukuhara T; Maemondo M; Kimura Y; Morikawa N; Watanabe H; Saijo Y; Nukiwa T;
Institution
Department of Respiratory Oncology and Molecular Medicine, Institute of Development, Aging, and Cancer, Tohoku University, 4-1, Seiryomachi, Aoba-ku, Sendai 980-8575, Japan. akinoue@idac.tohoku.ac.jp
Journal
J Clin Oncol. 2006 Jul 20;24(21):3340-6. Epub 2006 Jun 19.
Abstract URL
Click here to view abstract

18. Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.

Author
Kramer GW; Legrand CL; van Schil P; Uitterhoeve L; Smit EF; Schramel F; Biesma B; Tjan-Heijnen V; van Zandwijk N; Splinter T; Giaccone G; van Meerbeeck JP;
Institution
Radiotherapeutic Institute ARTI, Wagnerlaan 47, 6815 Arnhem, The Netherlands.
Journal
Eur J Cancer. 2006 Jul;42(10):1391-8.
Abstract URL
Click here to view abstract

19. A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.

Author
Molina JR; Nikcevich D; Hillman S; Geyer S; Drevyanko T; Jett J; Verdirame J; Tazelaar H; Rowland K; Wos E; Kutteh L; Nair S; Fitch T; Flynn P; Stella P; Adjei AA;
Institution
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Journal
Cancer Invest. 2006 Jun-Jul;24(4):382-9.
Abstract URL
Click here to view abstract

20. Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Author
Brodowicz T; Krzakowski M; Zwitter M; Tzekova V; Ramlau R; Ghilezan N; Ciuleanu T; Cucevic B; Gyurkovits K; Ulsperger E; Jassem J; Grgic M; Saip P; Szilasi M; Wiltschke C; Wagnerova M; Oskina N; Soldatenkova V; Zielinski C; Wenczl M;
Institution
Medical University Hospital, Vienna, Austria.
Journal
Lung Cancer. 2006 May;52(2):155-63. Epub 2006 Mar 29.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10 11 12